| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/27/2013 | WO2013096802A1 Amplification primers and methods |
| 06/27/2013 | WO2013096799A1 Systems and methods for isolating nucleic acids from cellular samples |
| 06/27/2013 | WO2013096798A2 Amplification of a sequence from a ribonucleic acid |
| 06/27/2013 | WO2013096777A2 Integrated compound discovery systems and methods |
| 06/27/2013 | WO2013096733A1 Compositions and methods for detecting and identifying bacteria |
| 06/27/2013 | WO2013096692A1 Apparatus and methods for kinetic analysis and determination of nucleic acid sequences |
| 06/27/2013 | WO2013096661A1 Methylation biomarkers for ovarian cancer |
| 06/27/2013 | WO2013096480A2 Monitoring transformation of follicular lymphoma to diffuse large b-cell lymphoma by immune repertoire analysis |
| 06/27/2013 | WO2013096460A1 Pseudogenes and uses thereof |
| 06/27/2013 | WO2013096455A1 Methods for diagnosing and treating oncogenic kras-associated cancer |
| 06/27/2013 | WO2013096304A1 Apparatuses and methods for continuous flow dielectrophoretic separations |
| 06/27/2013 | WO2013096229A1 Phosphorothioate oligonucleotide-labeling of white blood cells |
| 06/27/2013 | WO2013096137A1 System and method to improve yield of sorted particles |
| 06/27/2013 | WO2013095956A1 Micro rna-148a as a biomarker for advanced colorectal cancer |
| 06/27/2013 | WO2013095941A1 Methods and kits for detecting subjects at risk of having cancer |
| 06/27/2013 | WO2013095935A1 Compositions and methods for diagnosing and treating hyperthyroidism in companion animals |
| 06/27/2013 | WO2013095896A1 Photoactivated chemical bleaching of dyes |
| 06/27/2013 | WO2013095793A1 Identification of multigene biomarkers |
| 06/27/2013 | WO2013095329A1 Air quality sensor comprising a mitochondrial particle |
| 06/27/2013 | WO2013095303A1 A microarray and method for forming the same |
| 06/27/2013 | WO2013095137A2 Methods, means and kits for detecting scarce analytes |
| 06/27/2013 | WO2013095119A1 Identification of poliovirus strains |
| 06/27/2013 | WO2013095002A2 Method for sterilizing microbial cells using polyethylene glycol-based nonionic surfactant |
| 06/27/2013 | WO2013094748A1 Temperature-sensitive fluorescent probe for introduction into cell |
| 06/27/2013 | WO2013094676A1 Hydroxymethylfurfural derivative |
| 06/27/2013 | WO2013094579A1 Method for analyzing formyl glycine residue |
| 06/27/2013 | WO2013094418A1 Planar patch clamp device, electrodes for said device and cell ion channel current measurement method |
| 06/27/2013 | WO2013094316A1 Micro-/nanofluidic analyzer and method for manufacturing same |
| 06/27/2013 | WO2013093992A1 Oligonucleotide set for detecting hepatitis b virus group and evaluating gene diversity, and method using same |
| 06/27/2013 | WO2013093961A1 Object selecting device and object selecting method |
| 06/27/2013 | WO2013093644A2 Expression signature for staging and prognosis of prostate, breast and leukemia cancers |
| 06/27/2013 | WO2013093530A1 Method for determining the sequence of fragmented nucleic acids |
| 06/27/2013 | WO2013093507A1 Assay of functional cell viability |
| 06/27/2013 | WO2013093498A1 Diagnostic test for bacterial pathogens using internal control bacterial strain |
| 06/27/2013 | WO2013093489A2 Detection and treatment of breast cancer |
| 06/27/2013 | WO2013093483A1 A method for identifying a target polymer |
| 06/27/2013 | WO2013093432A1 Method for enriching and detection of variant target nucleic acids |
| 06/27/2013 | WO2013093407A1 Product selection using genetic analysis |
| 06/27/2013 | WO2013093356A2 Method for the diagnosis or prognosis, in vitro, of testicular cancer |
| 06/27/2013 | WO2013093353A2 Method for the diagnosis or prognosis, in vitro, of lung cancer |
| 06/27/2013 | WO2013093347A2 A method for the in vitro diagnosis or prognosis of ovarian cancer |
| 06/27/2013 | WO2013093329A1 Use of microrna molecules to influence skin pigmentation |
| 06/27/2013 | WO2013093324A2 Method for the diagnosis or prognosis, in vitro, of prostate cancer |
| 06/27/2013 | WO2013093316A2 Method for in vitro diagnosis or prognosis of breast cancer |
| 06/27/2013 | WO2013093315A2 Method for in vitro diagnosis or prognosis of colon cancer |
| 06/27/2013 | WO2013093170A1 Methods and compositions for determining the diversity of the t-lymphocyte repertoire of an individual |
| 06/27/2013 | WO2013093106A1 Detection of meca variant strains of methicillin-resistant staphylococcus aureus |
| 06/27/2013 | WO2013093091A2 Genetic factors in blood pressure |
| 06/27/2013 | WO2013093016A1 Diagnosis of steatohepatitis |
| 06/27/2013 | WO2013093015A1 Diagnosis of steatohepatitis |
| 06/27/2013 | WO2013093005A1 Method of dna detection and quantification by single-molecule hybridization and manipulation |
| 06/27/2013 | WO2013092960A1 Methods and kits for the diagnosis of colorectal cancer |
| 06/27/2013 | WO2013092845A1 Method for determining an analyte concentration |
| 06/27/2013 | WO2013092839A1 Method for detection of kras mutations |
| 06/27/2013 | WO2013092810A1 Methods relating to idiopathic pulmonary fibrosis (ipf) |
| 06/27/2013 | WO2013092275A2 Genes to enhance the defense against pathogens in plants |
| 06/27/2013 | WO2013091924A1 Applications of an immune system-released activating agent (israa) |
| 06/27/2013 | WO2013091835A1 Methods and reagents for reducing non-specific amplification |
| 06/27/2013 | WO2013091614A1 Method for the electrochemical detection of nucleic acid oligomer hybridisation occurrences |
| 06/27/2013 | WO2013091472A1 Method and device for performing polymerase chain reaction under constant heat reservoir |
| 06/27/2013 | WO2013091276A1 Method for detecting deletion and/or duplication of exons in dmd gene |
| 06/27/2013 | WO2013091120A1 Protected linker compounds |
| 06/27/2013 | WO2013091113A1 A method of predicting outcome in cancer patients |
| 06/27/2013 | WO2013091102A1 Enrichment & isolation of microbial cells & microbial nucleic acids from a biological sample |
| 06/27/2013 | WO2013091089A1 Three-dimensional cavities of dendritic cell immunoreceptor (dcir), compounds binding thereto and therapeutic applications related to inhibition of human immunodeficiency virus type-1 (hiv-1) |
| 06/27/2013 | WO2013091074A1 Method and array for identifying histone-code-related analytes |
| 06/27/2013 | WO2013074546A8 Two- chamber dual-pore device |
| 06/27/2013 | WO2013064702A3 Probes for diagnosis and monitoring of neurodegenerative disease |
| 06/27/2013 | WO2013052946A9 Genetically encoded biosensors |
| 06/27/2013 | WO2013049822A3 Diagnostic method for determining animals persistently infected (pi) with bovine viral diarrhea virus (bvdv) |
| 06/27/2013 | WO2013042993A3 Sprex-dna chip kit for detecting high-resolution mica alleles |
| 06/27/2013 | WO2013040478A3 Hyr1-derived compositions and methods of treatment using same |
| 06/27/2013 | WO2013040216A3 Digital bridge pcr |
| 06/27/2013 | WO2013040062A3 Characterizing multiple sclerosis |
| 06/27/2013 | WO2013022961A8 Compositions and methods for co-amplifying subsequences of a nucleic acid fragment sequence |
| 06/27/2013 | WO2013003849A4 Process and apparatus for quantifying nucleic acid in a sample |
| 06/27/2013 | WO2012160091A3 Sensor device for detecting an analyte |
| 06/27/2013 | WO2012159754A3 Individualized vaccines for cancer |
| 06/27/2013 | WO2012135841A3 Emt signatures and predictive markers and method of using the same |
| 06/27/2013 | WO2012120377A3 Molecular biomarker set for early detection of ovarian cancer |
| 06/27/2013 | WO2012062753A9 Method and device for isolating and purifying double-stranded nucleic acids |
| 06/27/2013 | WO2009123736A3 Process and method for monitoring gastrointestinal microbiota |
| 06/27/2013 | US20130167270 Method for differentiating fertile and sterile plant lines by detection of polymorphic markers in chloroplast dna |
| 06/27/2013 | US20130167260 Soybean cultivar ar0902031 |
| 06/27/2013 | US20130165745 Imaging and evaluating embryos, oocytes, and stem cells |
| 06/27/2013 | US20130165497 Monitoring of immune system using peripheral blood micro-rna expression profile analysis and uses thereof |
| 06/27/2013 | US20130165470 Methods for Detecting and Treating Rhinovirus Infection |
| 06/27/2013 | US20130165369 METHOD OF TREATING OBESITY AND METABOLIC DISORDERS RELATED TO EXCESS ADIPOSE TISSUE BY ADMINISTRATION OF sFRP-- PEPTIDE |
| 06/27/2013 | US20130165343 Identification of multigene biomarkers |
| 06/27/2013 | US20130165341 Structure-activity relationships |
| 06/27/2013 | US20130165336 Biomarkers for Diagnosing Schizophrenia and Bipolar Disorder |
| 06/27/2013 | US20130165334 Integrated assay that combines flow-cytometry and multiplexed hpv genotype identification |
| 06/27/2013 | US20130165333 Methods and Systems for Preparing Irreversible Inhibitors of Protein Tyrosine Phosphatases |
| 06/27/2013 | US20130165331 Chromosome copy number gain as a biomarker of urothelial carcinoma lethality |
| 06/27/2013 | US20130165328 Apparatus and methods for kinetic analysis and determination of nucleic acid sequences |
| 06/27/2013 | US20130165327 Method for Sequencing a Polynucelotide Template |
| 06/27/2013 | US20130164844 Compounds and methods for improving cellular uptake of oligomeric compounds |
| 06/27/2013 | US20130164830 Combination Assay Device and Method for Detecting Compounds in Vaginal Fluid |
| 06/27/2013 | US20130164829 Specific Gene Polymorphisms in Breast Cancer Diagnosis, Prevention and Treatment |
| 06/27/2013 | US20130164817 Polypeptides having nucleic acid binding activity |